Skip to main content
Premium Trial:

Request an Annual Quote

Mapmygenome Raises $1.1M

NEW YORK (GenomeWeb) – Indian genomics firm Mapmygenome today announced a pre-Series A financing round to scale up its operations. 

A company spokesperson told GenomeWeb that Mapmygenome raised INR70 million ($1.1 million) in the financing round, which was the company's first since it was founded in 2013. Mapmygenome CEO Anu Acharya said that the firm intends on expanding its leadership team, sales and marketing operations, and genetic counseling network, as well as invest in some assets to scale up its research. 

Investors in the round included Aarti Grover, managing director of CMS Computers; Rajan Anandan, managing director of Google India; Arihant Patni, managing director at Hive Technologies; Satveer Singh Thakral, CEO of Singapore Angel Network; and others. 

Based in Hyderabad, Mapmygenome offers products in personal genomics, molecular diagnostics, DNA forensics, and brain wellness.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.